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Abstract
Many well-powered genome-wide association studies have identified genetic determi-
nants of self-reported smoking behaviors and measures of nicotine dependence, but
most have not considered the role of structural variants, such as copy number variation
(CNVs), influencing these phenotypes. Here, we included 2,889 African American and
6,187 non-Hispanic White subjects from the COPDGene cohort (http://www.copdgene.
org) to carefully investigate the role of polymorphic CNVs across the genome on various
measures of smoking behavior. We identified a CNV component (a hemizygous deletion)
on chromosome 3p26.1 associated with two quantitative phenotypes related to smoking
behavior among African Americans. This polymorphic hemizygous deletion is signifi-
cantly associated with pack-years and cigarettes smoked per day among African Ameri-
can subjects in the COPDGene study. We sought evidence of replication in African
Americans from the population based Atherosclerosis Risk in Communities (ARIC) study.
While we observed similar CNV counts, the extent of exposure to cigarette smoking
among ARIC subjects was quite different and the smaller sample size of heavy smokers
in ARIC severely limited statistical power, so we were unable to replicate our findings
from the COPDGene cohort. But meta-analyses of COPDGene and ARIC study subjects
strengthened our association signal. However, a few linkage studies have reported sug-
gestive linkage to the 3p26.1 region, and a few genome-wide association studies
(GWAS) have reported markers in the gene (GRM7) nearest to this 3p26.1 area of
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polymorphic deletions are associated with measures of nicotine dependence among sub-
jects of European ancestry.
Introduction
Cigarette smoking is the leading environmental risk factor for many chronic diseases including
chronic obstructive pulmonary disease (COPD), coronary artery disease and several common
cancers [1, 2]. Different quantities and patterns of exposure to cigarette smoking can reflect dif-
ferent levels of nicotine dependence, in addition to the ease of access to cigarettes and other
social forces. Smoking behavior is a complex phenotype because it has both genetic [3, 4] and
non-genetic components (including social and environmental factors). To undertand the
genetic underpinning of this complex phenotype, several large-scale GWAS have been con-
ducted on quantitative measures of smoking behavior, but the majority of studies included sub-
jects of European ancestry, although there have been a few studies of African-American and
Asian populations. These previous studies have identifiedmultiple genetic loci significantly
associated with smoking behaviors [4–9].
While many genome-wide and candidate gene studies have identified common and rare sin-
gle nucleotide polymorphism (SNP) markers associated with quantitative measures of smoking
behaviors [10–12], to our knowledge none have focused on the association between copy num-
ber variants (CNVs) and quantitative measures of smoking behaviors or nicotine dependence.
This study focuses on testing for association between polymorphic CNVs and different pheno-
types reflecting smoking behavior in a sample of adult smokers drawn from the COPDGene
study, a large study of current and former smokers including both non-Hispanic White
(NHW) and African American (AA) adults (aged 45 or over) with at least 10 pack-years expo-
sure to cigarette smoking. Structural variants (including CNVs such as deletions and amplifica-
tions of segments of DNA) can be estimated from the genome-wide SNP marker panels used
for GWAS, but individuals can have a wide variety of CNVs, differing in both size and location.
Polymorphic CNVs, which are deletions/amplifications that are common in a population
(above 1% frequency), can be used in tests of association, just like SNPs. We hypothesized that
CNVs could be significantly associated with smoking-related phenotypes. However, because
CNVs are based on estimated deletions/amplifications, inferences based on significant associa-
tion tests can bemore tenuous, although they can still identify genes potentially influencing
complex phenotypes, such as quantitative measures of smoking behavior.
Materials and Methods
Ethics Statement
Written informed consent was obtained from all COPDGene study participants, with IRB
approvals at the 21 participating clinical centers. The full names of the ethics committee/insti-
tutional review boards with the protocol numbers that approved this study are presented in S1
Table.
Subjects
The COPDGene study (NCT00608764, www.copdgene.org) recruited a total of 10,192 adult
smokers [13] and approximately one-third of them are self-identifiedAA and two-thirds are
NHW. This cohort of current and former smokers included individuals ranging across all four
Copy Number Variants and Smoking Behavior
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severity classes of COPD as defined by the Global Initiative for Chronic Obstructive Lung Dis-
ease (GOLD COPD) guidelines[14, 15], as well as individuals with normal pulmonary function
and individuals with abnormally restricted spirometric values[16]. COPDGene collected infor-
mation on detailed personal smoking history for all study subjects, along with other demo-
graphic and behavioral risk factors. The complete questionnaire used is available on the
COPDGenewebsite [13].
Phenotypes of Interest
In this study, we considered two quantitative smoking phenotypes: average number of ciga-
rettes smoked per day and pack-years of smoking history. Pack-years is defined as the reported
average number of packs of cigarettes smoked per day times the years of smoking. Both of
these phenotypes are continuous in nature, but not normally distributed. Therefore, we log-
transformed both phenotypes before analysis, in addition to considering categories of the aver-
age number of cigarette smoked per day as an ordinal phenotype.We recoded the average
number of cigarettes smoked per day phenotype as 1 if 10 or less cigarettes were smoked, 2 if
greater than 10 and less or equal to 20 cigarettes were smoked, etc., finally coding category 7 if
more than 60 cigarettes per day were smoked.
Genotyping and Calling Copy Numbers
DNA was extracted from whole blood and genotyped on the Illumina Omni-Express chip. Pre-
vious articles on COPDGene genome-wide association analyses reported details of initial quality
control (QC) of genotype data [13, 17–23]. GWAS QC steps also included principal compo-
nents calculation for both AA and NHW groups separately to summarize and adjust for their
genetic ancestry. The hiddenMarkov model (HMM) based PennCNV algorithmwas used to
estimate CNVs exploiting the log R ratios (LRRs) and B allele frequencies (BAFs) from Illumi-
na’s Omni-Express probes [24]. After CNV calling and QC, there were 9,076 samples (6,187
NHWs; 2,889 AAs) available for analysis of polymorphic CNVs (S1 Fig). Polymorphic CNVs
were identifiedwithin each racial group, and those CNVs with>1% frequency among all sub-
jects passing QCwithin each racial group became the geneticmarkers of interest for this analy-
sis. Details of the QC process and CNV calling steps are discussed in Begumet al. (2015) [25].
Testing for Association
The genome-wide CNV distribution is very different betweenAA and NHW subjects, so we
estimated all CNV components separately for the two racial groups, and we performed strati-
fied genome-wide CNV association analyses for each group. Our main focus in this analysis
was to test for association between polymorphic CNVs and quantitative phenotypes describing
smoking behaviors. Calling of CNV components is described in Younkin et al. and Begum
et al. [25, 26]. Log10-transformed values of pack-years were used for the heavily (right) skewed
data (S2 Fig), and we categorized average number of cigarette smoked per day into 7 categories,
and considered that as a continuous phenotype. Linear regression models were used to assess
the relationship between a quantitative smoking phenotype and polymorphic CNVs while
adjusting for covariates such as gender and age. The average admixture score [27], which sum-
marizes the average European ancestry among AA subjects, was also considered in the analysis
of all AA subjects.
We then adjusted for multiple comparisons for the number of polymorphic CNVs within
each racial group by designing a permutation test. In this permutation, we randomly assigned
deletions and their accompanied average admixture score to all AA subjects and computed the
minimum p-value for each replicate set.We repeated this procedure 10,000 times to establish
Copy Number Variants and Smoking Behavior
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the genome-wide significance level with a family-wise error rate of 5%; and the nominal thresh-
old was set at 3.50, which is the 5th percentile -log10(p) maxima over all 10,000 replicates. A test
result was considered significant if it was lower than this threshold. Besides the PennCNV anal-
ysis, we used R to carry out our association analyses for this study (http://cran.r-project.org/).
Results
Out of 10,192 COPDGene study subjects, 9,970 passed initial GWAS QC. Additional QC for
CNV estimation excluded 894 subjects, leaving 9,076 subjects (2,889 AAs; 6,187 NHWs) for
analysis of polymorphic CNVs. Table 1 presents the demographic characteristics and distribu-
tion of the smoking phenotypes among males and females for these 2,889 AA and 6,187 NHW
subjects. None of our genome-wide CNV association results was significant in the larger group
of 6,187 NHWCOPDGene subjects, so we here limit our subsequent discussion to AA subjects
only.
Polymorphic CNV Association Analysis of Pack-years of Smoking in AA
Subjects
Considering only polymorphic CNV components (i.e. those with>1% frequency among AA
subjects), there were genome-wide 373 CNV components encompassing 22 autosomes avail-
able for association testing among all 2,889 AA subjects.We adjusted for age, gender and
admixture scores (i.e., the estimated average European ancestry among AA subjects) in testing
for association with pack-years of smoking. Fig 1 shows the Manhattan plot of 373 polymor-
phic CNV components, and its correspondingQQ plot is presented in S3 Fig. After multiple
comparison adjustment, only one polymorphic CNV component on chromosome 3p26.1
(spanning 1,691 bp from position 6212573 to 6214264, hg18) showed genome-wide signifi-
cance (p = 0.00017; -log10(0.00017)~3.77) (S4 Fig). The raw intensity data (LRRs and BAFs) at
chr3p26.1 were of high quality, and all CNV calls were made with high confidence (see S5 Fig).
Fig 2 shows the mean pack-years and 95% confidence interval (CI) plots for different polymor-
phic CNV counts between 77 hemizygous deletion carriers and the remaining AA subjects for
this region of chr 3p26.1. Mean pack-years was statistically significantly different (p = 0.00629)
between 77 hemizygous deletion carriers and rest of the AA individuals.
Although one polymorphic CNV component of size 1,691bp, (occuring as a hemizygous
deletion in 77 AA subjects) was significant in our permutation analysis, further investigation
showed this 1,691bp deletion is part of a larger section of polymorphic deletions on chr3p26.1
spanning approximately 20kb (6214264–6194430 = 19,834bp). There were 40 additional AA
subjects carrying smaller hemizygous deletions upstream of this region, bringing the total
Table 1. Demographic characteristics and smoking behavior distributions among African-American
and Non Hispanic White study subjects from COPDGene.
African-American (AA) Total
(Male: Female)
Non Hispanic White (NHW) Total
(Male: Female)
Sample size 2889 (1648 M: 1241 F) 6187(3262 M: 2925 F)
Mean age at enrollment 54.5(54.3 M: 54.8 F) 62.1 (62.4 M: 61.7 F)
Percent current smokers
(%)
80.5(82.9 M: 77.2 F) 39.3 (40.25 M: 38.22 F)
Mean pack-years of
smoking
38.1 (38.8 M: 37.2 F) 47.3 (51.6 M: 42.55 F)
Average cigarette smoked
per day
21.2 (21.5M: 20.8F) 25.8(27.6 M: 23.8 M)
doi:10.1371/journal.pone.0164134.t001
Copy Number Variants and Smoking Behavior
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number of hemizygous deletion carriers to 117. Among all 117 subjects with any estimated
deletion in this region, the 77 subjects carrying larger deleted segments of 1,691bp showed sig-
nificant association. This region is an intergenic region, which includes somemicroRNAs, and
the nearest known gene is GRM7 (chr3: 6,877,927–7,758,217; Size: 880kb) which is approxi-
mately 600kb away from the most significant polymorphic CNV segment observedhere.
The demographic and clinical characteristics of 2,772 normal diploid subjects and 117 sub-
jects with hemizygous deletions (77 of those 117 with larger hemizygous deletions, spanning
the significant polymorphic CNV component and 40 other individuals with shorter deletions)
are presented in Table 2. We did not observe any significant difference between these two
groups of hemizygous deletion carriers for demographic and clinical characteristics. However,
the pack-years of smoking was significantly different (p = 0.0006055) between the 77 carriers
with larger deletions and the 40 AA subjects carrying smaller deletions.
We also looked at COPDGene 6,187 NHW subjects and found there were only 3 hemizy-
gous deletion carriers and one subject with an amplification in 3p26.1 (spanning 1,691 bp from
position 6212573 to 6214264, hg18), which shows this CNV component is specific to people of
AA ancestry.
Fig 1. Genome-wide CNV association scan for pack-years in African American COPDGene subjects: Each point
represents a CNV component estimated by PennCNV. The red dotted line at 3.5 represents the genome-wide significance
levels needed to maintain a family-wise error rate (FWER) of 5%, obtained via 10,000 permutation tests. The black dotted line
at 3.87 represents the genome-wide significance levels for Bonferroni correction. 22 vertical bands indicate the 22 autosomes
examined.
doi:10.1371/journal.pone.0164134.g001
Copy Number Variants and Smoking Behavior
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Polymorphic CNV Association Analysis of Average Cigarette Smoking
Per Day Among AA Subjects
The polymorphic CNV component on chromosome 3p26.1 associated with pack-years of
smoking also showed border-line significance (p = 0.000254, -log10(p) = 3.59) for the average
cigarette smoking per day phenotype among all 2,889 AA subjects (S6 Fig). Again, age and gen-
der, plus average admixture scores (i.e., the estimated percent European ancestry among AA
subjects) were included as covariates.
Replication in Atherosclerosis Risk in Communities (ARIC) Study
To validate our CNV estimations on this region of chromosome 3p26.1 (6194430bp to
6214264bp), we further investigated CNV estimation in the ARIC study [28], which included
9,043 European American (EA) subjects and 3,210 African American (AA) subjects drawn
Fig 2. Mean and 95% Confidence Interval (CI) plot of pack-years for two groups of AA subjects. a. Mean
pack-years and 95%CI in 77 hemizygous deletion carriers vs. rest of the subjects(2812) in chr 3p26.1. The
observed mean difference in pack-years was statistically significantly (p = 0.00629) between these two groups.
doi:10.1371/journal.pone.0164134.g002
Copy Number Variants and Smoking Behavior
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frommultiple communities. Genotyping for the ARIC study was done on a different platform
(the Affymetrix 6.0 chip), but PennCNV was also used to estimate CNVs [29]. Copy number
estimates from a mixture model fit to the median LRR from this region among all ARIC AA
subjects revealed: 3 homozygous deletions, 170 hemizygous deletions, and 3,037 normal dip-
loid genotypes. Similarly, the CNV component counts for the specific 1,691 bp deletion achiev-
ing genome-wide significance in the COPDGene study identified 3 homozygous deletion
carriers and 145 hemizygous deletion carriers among all ARIC AA subjects. Therefore, the
counts of CNVs from the ARIC study among AAs are quite comparable with those seen in
COPDGene, confirming this polymorphic deletion is more common among AA subjects.
Among AA subjects in the ARIC cohort (a less selected cohort of adults, including many non-
smokers), however, only 52.6% were ever smokers, whereas COPDGene study subjects were all
smokers with at least 10 pack-years exposure. After sub-setting the ARIC cohort into those
subjects with at least 10 pack-years of smoking, only 973 AA subjects were left for analysis, but
the mean pack-years of smoking 29.8 was lower in the ARIC study compared to mean pack-
years of smoking 38.1 for COPDGene study subjects. Among these 973 AA subjects, 47 were
hemizygous deletion carriers and the remaining were normal diploids. Similar regression anal-
ysis of pack-years of smoking on polymorphic CNVs in this sub-set of AA subjects from ARIC
showed no significant association between this CNP component on 3p26.1 and pack-years of
smoking (p = 0.115), although the direction of the estimated effect size was the same (see S2
Table).
While we were not able to replicate this result in the ARIC study, a SNP (rs6762258) on
chromosome 3 in GRM7was marginally associated with the log10(pack-years) adjusting for
age, gender, and genetic ancestry via PCAs (p = 0.004) among AA in the COPDGene study.
Table 2. Details on 2,772 AA normal diploid subjects and 117 AA subjects with hemizygous deletions on chr 3p26.1 (77 of these 117 AA subjects
carryied CNV components achieving genome-wide significance had larger hemizygous deletions (spanning an additional 1.6kb), while 40 of 117
AA subjects had shorter hemizygous deletions in this section).
2772 AA normal diploid subjects 40 subjects with shorter deletions 77 subjects with larger deletions
Gender
Male 1567 (56.5%) 24 (60%) 57 (74%)
Female 1205 (43.5%) 16 (40%) 20 (26%)
Current smoker 2230 (80.4%) 35 (87.5%) 60 (77.9%)
Male 1302 (58.4%) 20 (57.1%) 45 (75%)
Female 928 (41.6%) 15 (42.9%) 15 (25%)
Ex-smoker 542 (19.6%) 5 (12.5%) 17 (22.1%)
Male 265 (48.9%) 4 (80%) 12 (70.6%)
Female 277 (51.1%) 1 (20%) 5 (29.4%)
Average smoking per day 21.1 19.0 25.7
Male 21.4 19.5 25.7
Female 20.8 18.3 25.9
Pack-years of smoking 37.9 33.3 47.5
Mean age at enrollment
Male 54.4 52.7 53.2
Female 54.9 54.9 52.5
COPD status
Cases 2000 (72.1%) 27 (67.5%) 59 (76.6%)
Controls 565 (20.4%) 8 (20.0%) 14 (18.2%)
Unknowns 207 (7.5%) 5 (12.5%) 4 (5.2%)
doi:10.1371/journal.pone.0164134.t002
Copy Number Variants and Smoking Behavior
PLOS ONE | DOI:10.1371/journal.pone.0164134 October 6, 2016 7 / 13
This SNP (rs6762258) showed almost no correlation with the CNV component of interest (cor-
relation coefficient= 0.04; p = 0.03).
We also performedmeta-analysis of ARIC and COPDGeneAA study subjects for the pack-
years of smoking phenotype which improved the significance (p = 6.126e-05; -log10(6.126e-05)
~4.21) compared to the p-values obtained from COPDgene study alone (p = 0.00017;
-log10(0.00017)~3.77).We checked for association between polymorphic CNVs with the aver-
age cigarette smoked per day among AAs in the ARIC study. The average cigarette smoked per
day among AAs in ARIC was 19.2, and was slightly lower than cigarettes per day reported by
AA subjects in COPDGene study 21.2. Although the reported average cigarettes smoked per
day was not significantly associated with the polymorphic CNV on chr. 3p26.1 (p = 0.221) in
the ARIC study (see S2 Table), a meta-analysis combining AA subjects from ARIC and COPD-
Gene study improved the significance (p = 0.0001577; -log10(0.0001577)~3.80) compared to
the p-values obtained from COPDgene study alone (p = 0.000254, -log10(p) = 3.59).
Discussion
In this study, we performed a genome-wide association study of polymorphic copy number var-
iants (CNVs) and quantitative measures of smoking behavior using subjects from the COPD-
Gene study cohort of 9,076 subjects (stratified by race).We performed stratified analysis in
NHW (n = 6,187) and AA (n = 2,889) subjects separately, but we only found genome-wide sig-
nificant evidence of association between polymorphic CNVs on chromosome 3p26.1 and smok-
ing behavior among African American subjects, where these CNVs are far more polymorphic.
Deletions in this 1.6 kb region were significantly associated with two quantitative measures of
smoking behavior: pack-years of smoking and average number of cigarette smoked per day.
Hemizygous deletion carriers were more common among AA subjects (a total of 117 but 77 had
larger deletions driving the association signal) compared to NHW subjects, i.e. there were only 3
NHW subjects with a hemizygous deletion and one subject with one copy amplification in that
area among a total of 6,187 NHW subjects in COPDGene study and 7 EA subjects with hemizy-
gous deletion and 21 subjects with single copy gain in the ARIC study. People of African ances-
try often have more polymorphic CNVs and other forms of geneticmarkers compared to
people of European ancestry [30, 31]. African Americans in the ARIC[32] study showed similar
counts of hemizygous deletion carriers and normal diploids, but the substantial differences in
the quantity of exposure to cigarette smoking in the community-basedARIC cohort severely
limited statistical power to replicate this association seen in COPDGene.When we used a simi-
lar regressionmodel on heavy smokers among African American ARIC participants, there were
fewer than 1,000 subjects with available phenotype and CNV data, so it is not surprising that no
significant results were obtained. A formal power analysis supported this claim (see S8 Fig).
Nonetheless, this finding of association between polymorphic deletions on chromosome 3p26.1
may help to better understand genetic factors controlling smoking behavior.
There are several genome-wide studies of SNP markers where smoking behaviors (including
pack-years, nicotine dependence, etc.) have been used as outcome phenotypes. Several have
achieved genome-wide significance among European Americans, but fewer among African
Americans. In a recent meta-analysis of four smoking behavior phenotypes, David et al. [33]
identified one SNP in chr 15q25.1 achieving genome-wide significance in a combined sample
of 15,547 African American subjects from 13 studies with the phenotype cigarettes per day.
This region of chr15q25.1 has shown strong and consistent evidence of association with nico-
tine dependence, smoking intensity and lung cancer risk in samples of European ancestry.
These authors suggest this one SNP achieving genome-wide significancemay define a single
common haplotype exerting some effect on smoking behaviors. Among the second-tier hits
Copy Number Variants and Smoking Behavior
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identified in this meta-analysis were some novel genes, but none could account for much of the
variance in quantitative measures of smoking behavior. In a candidate gene approach, Saccone
et al. [34] confirmed a well-recognizedassociation between a non-synonymous, functional
SNP (rs16969968) in chr 15q25 and nicotine dependence in both European Americans and
African Americans in a case-control study of confirmed smokers, but other markers in this
region showed more complex statistical evidence of association, as well as greater heterogeneity
between racial groups. Gelernter et al. [5] looked at nicotine dependence in a GWAS using
2,114 European American and 2,602 African American smokers, althoughmost genome-wide
significant SNPs were only supported in one racial group. In part, this difference in evidence of
association between smoking behavior phenotypes in GWAS or candidate gene studies may
reflect background differences in linkage disequilibrium (LD) patterns between people of Euro-
pean and African ancestry, but also differences in marker allele frequencies and differences in
sample sizes become important (where studies of African Americans are typically smaller).
Hamidovic et al. [35] showed a quantitative assessment of smoking persistence (based on
pack-years) also revealed different patterns of association with SNPs between European and
African ancestry subjects from the ARIC study cohort. However, in an analysis of the MESA
Lung cohort, Powell et al. [36] could not demonstrate any differences across four racial/ethnic
groups in the association between smoking behaviors and quantitative measures of spirometric
lung function or emphysema.
There are no published studies of polymorphic CNVs influencing quantitative measures of
smoking behaviors directly in either racial group, but linkage analysis studies from “The Nico-
tine Addiction Genetics linkage project” showed this chromosome 3p26-25 region was linked
to depression with a multiponint LOD score of 4.14 in heavy smoker families, highlighting the
need for further investigation into this genomic region [37, 38]. Here, we explored the effects
of common deletions/amplifications on pack-years and reported number of cigarettes per
day. Only the smaller African American sub-group achieved genome-wide significance, per-
haps because they have more hemizygous deletion carriers (117) on chr3p26.1 compared to
NHW (where there was only 3 hemizygous deletion carriers and one duplication carrier). The
nearest gene to our most strongly associated CNV component on chromosome 3p26.1 dele-
tion region is GRM7, which is involved with glutamate receptor activation. Several previous
GWAS studies of nicotine dependence-related phenotypes have reported associations to
markers in GRM7 [39–42]. Examining gene expression levels of GRM7 in the GTEx portal
(http://www.gtexportal.org/home/gene/GRM7) showed higher expression in different parts of
brain including the cortex, hypothalamus and hippocampus (S7 Fig), which included 84.3%
NHW and 13.7% African Americans in their expression analysis. Liu et al.[40] performed a
combined analysis of pooledDNA samples from both European and African American sub-
jects in a case-control study of substance dependence, and GRM7 was among the many genes
showing some evidence of allele frequency differences between cases and controls. A related
gene (GRM8 on chr. 7) was identified in another study of heroin addiction, but the relation-
ship between quantitative measures of smoking behavior and other substance abuse remains
tenuous [43]. This is the first study of polymorphic structural variants (CNVs) and quantita-
tive measures of smoking behavior, and the first time any association between polymorphic
CNVs on chromosome 3p26.1 has been reported to be associated with relatively heavy smok-
ers among African American subjects.
Supporting Information
S1 Fig. Data QC pipeline: 10,192 subjects were genotypedwith the IlluminaOmniExpress
chip. After QC 9,970 subjects were included in GWAS analysis. Among those subjects, 9,149
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passed PennCNV QC. Due to poor CNV calling, an additional 73 subjects from 4 plates were
excluded. 9,076 subjects were included in CNV analysis (2889 AA subjects and 6187 NHW
subjects).
(PDF)
S2 Fig. Distribution of pack-years and log-transformedpack-years among COPDGeneAA
subjects.
(PDF)
S3 Fig. Quantile-Quantile(Q-Q) plot (λ = 1.02) of the genome-wideCNP association study
with pack-years of smoking among AA subjects. –log10 transformed observedp-values (Y-
axis) were plotted against–log10 transformed expected p-values (X-axis).
(PDF)
S4 Fig. Histogram of 10,000 permuted p-values and the observedp-values (denoted by the
red dotted line).
(PDF)
S5 Fig. B allele frequency (BAF) and LogR Ratio (LRR) plot of deleted and normal sub-
jects. Top panel: a. BAF plot of observedmarkers from 77 subjects with hemizygous deletions
b. LRR intensities for these same 77 subjects with hemizygous deletions Bottom panel: a. BAF
plot of 77 individuals called as normal diploids in this same region b. LRR plot of 77 diploid
subjects.
(PDF)
S6 Fig. Association plot and QQ plot (λ = 1.05) or association of copy number variants and
average cigarettes smoked per day for COPDGeneAA subjects.
(PDF)
S7 Fig. Gene expression for GRM7. Data Source: GTEx Analysis ReleaseV6 (dbGaPAcces-
sion phs000424.v6.p1) (http://www.gtexportal.org/home/gene/GRM7).
(PDF)
S8 Fig. Power analysis plot: As mentioned in the Discussion section of the manuscript, we
feel that differences in the quantity of exposure to cigarette smoking in the community-
basedARIC cohort severely limited statistical power to replicate our findings.To support
this claim, we have conducted the following power analysis. We generated the outcome (log
transformed pack-years of smoking history) from a normal distribution based on the CNV of
interest for varying effect sizes (Beta ranging from 0 to 1 by 0.005) for 2,889 subjects, the sam-
ple size of COPDGeneAA subjects, and 973 subjects, the sample size of the ARIC study for
subjects with at least 10 pack-years of smoking history. As seen in this figure, there was sub-
stantially more power to detect an association among the sample size of the COPDGene study
as compared to the sample size from the AIRC study.
(PDF)
S1 Table. Estimated regression coefficients.
(PDF)
S2 Table. Estimated regression coefficients from linear regressionmodels testing for associ-
ation between pack-years/cigarettesper day and polymorphicdeletionCNVs on chr 3p26
in COPDGene& ARIC AfricanAmericans.
(PDF)
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